Panadol — Class III drug recall D-1287-2015
Terminated recall by GlaxoSmithkline Consmer Healthcare, reported 2015-08-12, distributed in PR. Failed Dissolution Specifications
| Recall number | D-1287-2015 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | GlaxoSmithkline Consmer Healthcare, Moon Township, PA, United States |
| Recall initiated | 2015-06-30 |
| Classified | 2015-08-05 |
| Reported by FDA | 2015-08-12 |
| Terminated | 2017-02-28 |
| Distributed | PR |
| Quantity | 17,675 cases |
| Reason classes | specification failure |
| NDC | 00135-0135-02, 00135-0135-03, 00135-0135-04 |
| Expiration dates | 2015-10-31, 2015-11-30, 2016-02-29, 2016-04-30, 2017-01-31, 2018-02-01 |
Product
Panadol (acetaminophen) Extra Strength, 500 mg, a) 30 count (UPC 1-03-53100-91070-8, NDC 0135-0135-02), b) 60 count (UPC 1-03-53100-91080-7, NDC 0135-0135-03) and c) 100 count (UPC 1-03-53100-91090-6, NDC 0135-0135-04) bottles, Distributed by: GlaxoSmithKline Consumer Healthcare L.P, Moon Township, PA 15108
Reason for recall
Failed Dissolution Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1287-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.